• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

人 NPC1L1 表达受 PPARα 的正向调节。

Human NPC1L1 expression is positively regulated by PPARα.

机构信息

Department of Pharmacy, The University of Tokyo Hospital Faculty of Medicine, The University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo, 113-8655, Japan.

出版信息

Pharm Res. 2011 Feb;28(2):405-12. doi: 10.1007/s11095-010-0294-4. Epub 2010 Oct 16.

DOI:10.1007/s11095-010-0294-4
PMID:20953676
Abstract

PURPOSE

Niemann-Pick C1-like 1 (NPC1L1), a pharmacological target of ezetimibe, is responsible for cholesterol absorption in enterocytes and hepatocytes. In the present study, the involvement of peroxisome proliferator-activated receptor α (PPARα) and its cofactor, PPARγ coactivator 1α (PGC1α) in the transcriptional regulation of human NPC1L1 was analyzed.

METHODS

Reporter gene assays and electrophoretic mobility shift assays (EMSAs) were performed with the 5'-flanking region of the human NPC1L1 gene and the effect of siPPARα was examined.

RESULTS

PPARα-mediated transactivation was observed with human NPC1L1 promoter constructs. Detailed analyses using deletion- and mutated-promoter constructs revealed the presence of a functional PPARα-response element (PPRE) upstream of the human NPC1L1 gene (-846/-834), a direct binding of PPARα and RXRα to which was confirmed by EMSAs. Moreover, PPARα-specific knockdown resulted in a significant decrease in the endogenous expression of NPC1L1 mRNA and protein in human-derived HepG2 cells. Furthermore, cotransfection of PGC1α stimulated the SREBP2/HNF4α- and PPARα/RXRα-mediated activation of the human NPC1L1 promoter.

CONCLUSIONS

We found that PPARα positively regulates human NPC1L1 transcription via direct binding to a PPRE. Additionally, PGC1α stimulates the SREBP2/HNF4α- and PPARα/RXRα-mediated transactivation of human NPC1L1. These findings may provide new insights into the close relationship of glucose, fatty acids and cholesterol homeostasis.

摘要

目的

尼曼-匹克 C1 样 1(NPC1L1)是依折麦布的药理靶点,负责肠细胞和肝细胞中的胆固醇吸收。在本研究中,分析了过氧化物酶体增殖物激活受体α(PPARα)及其共激活因子过氧化物酶体增殖物激活受体γ共激活因子 1α(PGC1α)在人 NPC1L1 转录调控中的作用。

方法

采用人 NPC1L1 基因 5'侧翼区进行报告基因检测和电泳迁移率变动分析(EMSA),并检测 siPPARα 的作用。

结果

观察到 PPARα 介导的人 NPC1L1 启动子构建体的转录激活。使用缺失和突变启动子构建体的详细分析显示,人 NPC1L1 基因上游存在功能性 PPARα 反应元件(PPRE)(-846/-834),通过 EMSA 证实了 PPARα 和 RXRα 的直接结合。此外,PPARα 特异性敲低导致人源性 HepG2 细胞中 NPC1L1 mRNA 和蛋白的内源性表达显著下降。此外,PGC1α 的共转染刺激了 SREBP2/HNF4α 和 PPARα/RXRα 介导的人 NPC1L1 启动子的激活。

结论

我们发现 PPARα 通过直接结合 PPRE 正向调节人 NPC1L1 转录。此外,PGC1α 刺激 SREBP2/HNF4α 和 PPARα/RXRα 介导的人 NPC1L1 转录激活。这些发现可能为葡萄糖、脂肪酸和胆固醇稳态的密切关系提供新的见解。

相似文献

1
Human NPC1L1 expression is positively regulated by PPARα.人 NPC1L1 表达受 PPARα 的正向调节。
Pharm Res. 2011 Feb;28(2):405-12. doi: 10.1007/s11095-010-0294-4. Epub 2010 Oct 16.
2
Fenofibrate reduces intestinal cholesterol absorption via PPARalpha-dependent modulation of NPC1L1 expression in mouse.非诺贝特通过过氧化物酶体增殖物激活受体α(PPARα)依赖性调节小鼠NPC1L1表达来降低肠道胆固醇吸收。
J Lipid Res. 2007 Dec;48(12):2725-35. doi: 10.1194/jlr.M700345-JLR200. Epub 2007 Aug 28.
3
HNF4alpha is a crucial modulator of the cholesterol-dependent regulation of NPC1L1.肝细胞核因子4α(HNF4α)是NPC1L1胆固醇依赖性调节的关键调节因子。
Pharm Res. 2008 May;25(5):1134-41. doi: 10.1007/s11095-007-9496-9. Epub 2007 Dec 14.
4
SREBP2 mediates the modulation of intestinal NPC1L1 expression by curcumin.SREBP2 介导姜黄素对肠道 NPC1L1 表达的调节作用。
Am J Physiol Gastrointest Liver Physiol. 2011 Jul;301(1):G148-55. doi: 10.1152/ajpgi.00119.2011. Epub 2011 Apr 28.
5
Niemann-pick C1-like 1 (NPC1L1) protein in intestinal and hepatic cholesterol transport.肠道和肝脏胆固醇转运中的尼曼-匹克 C1 样蛋白 1(NPC1L1)。
Annu Rev Physiol. 2011;73:239-59. doi: 10.1146/annurev-physiol-012110-142233.
6
Antiepileptic Drug-Activated Constitutive Androstane Receptor Inhibits Peroxisome Proliferator-Activated Receptor and Peroxisome Proliferator-Activated Receptor Coactivator 1-Dependent Gene Expression to Increase Blood Triglyceride Levels.抗癫痫药物激活的组成型雄烷受体抑制过氧化物酶体增殖物激活受体和过氧化物酶体增殖物激活受体共激活物 1 依赖性基因表达,增加血液甘油三酯水平。
Mol Pharmacol. 2020 Nov;98(5):634-647. doi: 10.1124/molpharm.120.000103. Epub 2020 Sep 5.
7
The target of ezetimibe is Niemann-Pick C1-Like 1 (NPC1L1).依泽替米贝的作用靶点是尼曼-匹克C1样1蛋白(NPC1L1)。
Proc Natl Acad Sci U S A. 2005 Jun 7;102(23):8132-7. doi: 10.1073/pnas.0500269102. Epub 2005 May 31.
8
Mouse OCTN2 is directly regulated by peroxisome proliferator-activated receptor alpha (PPARalpha) via a PPRE located in the first intron.鼠 OCTN2 可被过氧化物酶体增殖物激活受体 α(PPARα)直接调控,调控元件为位于第一内含子的 PPRE。
Biochem Pharmacol. 2010 Mar 1;79(5):768-76. doi: 10.1016/j.bcp.2009.10.002. Epub 2009 Oct 9.
9
Genetic demonstration of intestinal NPC1L1 as a major determinant of hepatic cholesterol and blood atherogenic lipoprotein levels.肠道NPC1L1作为肝脏胆固醇和血液致动脉粥样硬化脂蛋白水平主要决定因素的遗传学证明。
Atherosclerosis. 2014 Dec;237(2):609-17. doi: 10.1016/j.atherosclerosis.2014.09.036. Epub 2014 Oct 17.
10
Both the peroxisome proliferator-activated receptor delta agonist, GW0742, and ezetimibe promote reverse cholesterol transport in mice by reducing intestinal reabsorption of HDL-derived cholesterol.过氧化物酶体增殖物激活受体 δ 激动剂 GW0742 和依泽替米贝通过减少肠道对 HDL 来源胆固醇的重吸收促进了小鼠的胆固醇逆向转运。
Clin Transl Sci. 2009 Apr;2(2):127-33. doi: 10.1111/j.1752-8062.2009.00098.x.

引用本文的文献

1
The Role of Cholesterol Metabolism and Its Regulation in Tumor Development.胆固醇代谢及其调节在肿瘤发生中的作用。
Cancer Med. 2025 Apr;14(7):e70783. doi: 10.1002/cam4.70783.
2
Intestinal Pgc1α ablation protects from liver steatosis and fibrosis.肠道中过氧化物酶体增殖物激活受体γ共激活因子1α(Pgc1α)缺失可预防肝脂肪变性和肝纤维化。
JHEP Rep. 2023 Jul 19;5(11):100853. doi: 10.1016/j.jhepr.2023.100853. eCollection 2023 Nov.
3
Anti-Obesity Potential through Regulation of Carbohydrate Uptake and Gene Expression in Intestinal Epithelial Cells by the Probiotic MGEL20154 from Fermented Food.

本文引用的文献

1
Molecular mechanisms of membrane transport of vitamin E.维生素 E 的膜转运的分子机制。
Mol Nutr Food Res. 2010 May;54(5):616-22. doi: 10.1002/mnfr.200900481.
2
In-vitro characterization of the six clustered variants of NPC1L1 observed in cholesterol low absorbers.胆固醇吸收不良者中观察到的 NPC1L1 的六个聚集变体的体外特征。
Pharmacogenet Genomics. 2009 Nov;19(11):884-92. doi: 10.1097/FPC.0b013e3283327925.
3
Peroxisome proliferator-activated receptor delta activation leads to increased transintestinal cholesterol efflux.
通过发酵食品中的益生菌 MGEL20154 调节肠道上皮细胞中碳水化合物摄取和基因表达来实现抗肥胖潜力。
J Microbiol Biotechnol. 2023 May 28;33(5):621-633. doi: 10.4014/jmb.2212.12005. Epub 2023 Feb 6.
4
Bioactive Triterpenes of Gum Resin Extract Display Cholesterol-Lowering Potential.树胶树脂提取物中的生物活性三萜具有降低胆固醇的潜力。
Int J Mol Sci. 2021 Mar 6;22(5):2664. doi: 10.3390/ijms22052664.
5
Mechanisms and regulation of cholesterol homeostasis.胆固醇稳态的机制和调节。
Nat Rev Mol Cell Biol. 2020 Apr;21(4):225-245. doi: 10.1038/s41580-019-0190-7. Epub 2019 Dec 17.
6
The Effect of Polyphenols on Hypercholesterolemia through Inhibiting the Transport and Expression of Niemann-Pick C1-Like 1.多酚通过抑制 Niemann-Pick C1-like 1 的转运和表达对高胆固醇血症的影响。
Int J Mol Sci. 2019 Oct 6;20(19):4939. doi: 10.3390/ijms20194939.
7
Siamese neem flower extract suppresses cholesterol absorption by interfering NPC1L1 and micellar property and in intestinal Caco-2 cells.暹罗楝花提取物通过干扰NPC1L1和胶束性质以及在肠道Caco-2细胞中抑制胆固醇吸收。
Res Pharm Sci. 2019 Jun;14(3):190-200. doi: 10.4103/1735-5362.258485.
8
Transcriptional control of intestinal cholesterol absorption, adipose energy expenditure and lipid handling by Sortilin.Sortilin 对肠道胆固醇吸收、脂肪能量消耗和脂质处理的转录控制。
Sci Rep. 2018 Jun 13;8(1):9006. doi: 10.1038/s41598-018-27416-y.
9
Dyslipidaemia of diabetes and the intestine.糖尿病与肠道的血脂异常。
World J Diabetes. 2015 Jul 10;6(7):970-7. doi: 10.4239/wjd.v6.i7.970.
10
Transcriptional regulation of Niemann-Pick C1-like 1 gene by liver receptor homolog-1.肝脏受体同源物-1对尼曼-匹克C1样1基因的转录调控
BMB Rep. 2015 Sep;48(9):513-8. doi: 10.5483/bmbrep.2015.48.9.253.
过氧化物酶体增殖物激活受体 δ 的激活导致胆甾醇经肠排泄增加。
J Lipid Res. 2009 Oct;50(10):2046-54. doi: 10.1194/jlr.M800579-JLR200. Epub 2009 May 13.
4
FIC1-mediated stimulation of FXR activity is decreased with PFIC1 mutations in HepG2 cells.在HepG2细胞中,FIC1介导的法尼醇X受体(FXR)活性刺激随着进行性家族性肝内胆汁淤积症1型(PFIC1)突变而降低。
J Gastroenterol. 2009;44(6):592-600. doi: 10.1007/s00535-009-0041-y. Epub 2009 Apr 21.
5
Niemann-pick C1-like 1 mediates alpha-tocopherol transport.尼曼-匹克C1样蛋白1介导α-生育酚转运。
Mol Pharmacol. 2008 Jul;74(1):42-9. doi: 10.1124/mol.107.043034. Epub 2008 Apr 10.
6
CD36 mediates both cellular uptake of very long chain fatty acids and their intestinal absorption in mice.CD36介导超长链脂肪酸的细胞摄取及其在小鼠肠道中的吸收。
J Biol Chem. 2008 May 9;283(19):13108-15. doi: 10.1074/jbc.M708086200. Epub 2008 Mar 10.
7
Intestinal fatty acid binding protein regulates mitochondrion beta-oxidation and cholesterol uptake.肠道脂肪酸结合蛋白调节线粒体β-氧化和胆固醇摄取。
J Lipid Res. 2008 May;49(5):961-72. doi: 10.1194/jlr.M700363-JLR200. Epub 2008 Jan 30.
8
HNF4alpha is a crucial modulator of the cholesterol-dependent regulation of NPC1L1.肝细胞核因子4α(HNF4α)是NPC1L1胆固醇依赖性调节的关键调节因子。
Pharm Res. 2008 May;25(5):1134-41. doi: 10.1007/s11095-007-9496-9. Epub 2007 Dec 14.
9
Fenofibrate reduces intestinal cholesterol absorption via PPARalpha-dependent modulation of NPC1L1 expression in mouse.非诺贝特通过过氧化物酶体增殖物激活受体α(PPARα)依赖性调节小鼠NPC1L1表达来降低肠道胆固醇吸收。
J Lipid Res. 2007 Dec;48(12):2725-35. doi: 10.1194/jlr.M700345-JLR200. Epub 2007 Aug 28.
10
Hepatic Niemann-Pick C1-like 1 regulates biliary cholesterol concentration and is a target of ezetimibe.肝脏尼曼-匹克C1样蛋白1调节胆汁胆固醇浓度,是依泽替米贝的作用靶点。
J Clin Invest. 2007 Jul;117(7):1968-78. doi: 10.1172/JCI30060.